Anixa biosciences announces presentation on its ovarian cancer car-t therapy at the ovarian cancer research alliance's international gynecologic cancer conference

San jose, calif. , sept. 18, 2024 /prnewswire/ -- anixa biosciences, inc. ("anixa" or the "company") (nasdaq: anix), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the ovarian cancer research alliance's ("ocra") international gynecologic cancer conference taking place online september 25-27, 2024.
CAR Ratings Summary
CAR Quant Ranking